Advertisement
Screener

Minerva Neurosciences, Inc. (NERV) Increase (Decrease) in Accounts Payable

2.8 / 5 stars · 68/120 Roast Me

Minerva Neurosciences, Inc. Increase (Decrease) in Accounts Payable

Minerva Neurosciences, Inc. (NERV) reported Increase (Decrease) in Accounts Payable of $771.33 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-07

  • Minerva Neurosciences, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$693.74K, a 370.09% decline year-over-year.
  • Minerva Neurosciences, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $1.47M.
  • Minerva Neurosciences, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$275.23K, a 126.10% decline year-over-year.
  • Minerva Neurosciences, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$72.74K.
  • Minerva Neurosciences, Inc. increase (decrease) in accounts payable for fiscal 2025 was -$1.06M.
  • Minerva Neurosciences, Inc. increase (decrease) in accounts payable for fiscal 2024 was -$197.48K, a 123.63% decline from fiscal 2023.
  • Minerva Neurosciences, Inc. increase (decrease) in accounts payable for fiscal 2023 was $835.65K.
  • Minerva Neurosciences, Inc. increase (decrease) in accounts payable for fiscal 2022 was -$883.55K, a 203.03% decline from fiscal 2021.
Period endIncrease (Decrease) in Accounts Payable 3 monthIncrease (Decrease) in Accounts Payable 6 monthIncrease (Decrease) in Accounts Payable 9 monthIncrease (Decrease) in Accounts Payable 12 month
2026-06-30-$693.74K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
$771.33K
10-Q · filed 2026-08-07
$496.11K
derived: sum of 3 quarters · filed 2026-08-07
$423.37K
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31$1.47M
10-Q · filed 2026-05-05
$1.19M
derived: sum of 2 quarters · filed 2026-05-05
$1.12M
derived: sum of 3 quarters · filed 2026-05-05
$1.37M
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31-$275.23K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11
-$347.97K
derived: sum of 2 quarters · filed 2026-03-11
-$91.11K
derived: sum of 3 quarters · filed 2026-08-07
-$1.06M
10-K · filed 2026-03-11
2025-09-30-$72.74K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$184.11K
derived: sum of 2 quarters · filed 2026-08-07
-$783.78K
10-Q · filed 2025-11-05
$270.87K
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30$256.85K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
-$711.04K
10-Q · filed 2026-08-07
$343.61K
derived: sum of 3 quarters · filed 2026-08-07
$68.45K
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31-$967.90K
10-Q · filed 2026-05-05
$86.75K
derived: sum of 2 quarters · filed 2026-05-05
-$188.40K
derived: sum of 3 quarters · filed 2026-05-05
-$795.62K
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$1.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11
$779.50K
derived: sum of 2 quarters · filed 2026-03-11
$172.28K
derived: sum of 3 quarters · filed 2026-03-11
-$197.48K
10-K · filed 2026-03-11
2024-09-30-$275.15K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
-$882.38K
derived: sum of 2 quarters · filed 2025-11-05
-$1.25M
10-Q · filed 2025-11-05
-$841.88K
derived: sum of 4 quarters · filed 2025-11-05
2024-06-30-$607.22K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
-$976.98K
10-Q · filed 2025-08-14
-$566.73K
derived: sum of 3 quarters · filed 2025-08-14
$530.09K
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31-$369.75K
10-Q · filed 2025-05-13
$40.50K
derived: sum of 2 quarters · filed 2025-05-13
$1.14M
derived: sum of 3 quarters · filed 2025-05-13
$474.57K
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31$410.25K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
$1.51M
derived: sum of 2 quarters · filed 2025-02-25
$844.32K
derived: sum of 3 quarters · filed 2025-02-25
$835.65K
10-K · filed 2025-02-25
2023-09-30$1.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05
$434.07K
derived: sum of 2 quarters · filed 2024-11-05
$425.40K
10-Q · filed 2024-11-05
$862.18K
derived: sum of 4 quarters · filed 2024-11-05
2023-06-30-$662.75K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
-$671.42K
10-Q · filed 2024-08-06
-$234.64K
derived: sum of 3 quarters · filed 2024-08-06
-$1.22M
derived: sum of 4 quarters · filed 2024-08-06
2023-03-31-$8.67K
10-Q · filed 2024-05-01
$428.11K
derived: sum of 2 quarters · filed 2024-05-01
-$558.73K
derived: sum of 3 quarters · filed 2024-05-01
-$625.17K
derived: sum of 4 quarters · filed 2024-05-01
2022-12-31$436.78K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
-$550.06K
derived: sum of 2 quarters · filed 2024-02-22
-$616.50K
derived: sum of 3 quarters · filed 2024-02-22
-$883.55K
10-K · filed 2024-02-22
2022-09-30-$986.84K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
-$1.05M
derived: sum of 2 quarters · filed 2023-11-07
-$1.32M
10-Q · filed 2023-11-07
-$667.62K
derived: sum of 4 quarters · filed 2023-11-07
2022-06-30-$66.44K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01
-$333.49K
10-Q · filed 2023-08-01
$319.22K
derived: sum of 3 quarters · filed 2023-08-01
-$73.97K
derived: sum of 4 quarters · filed 2023-08-01
2022-03-31-$267.05K
10-Q · filed 2023-05-15
$385.66K
derived: sum of 2 quarters · filed 2023-05-15
-$7.53K
derived: sum of 3 quarters · filed 2023-05-15
$456.54K
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$652.71K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08
$259.52K
derived: sum of 2 quarters · filed 2023-03-08
$723.59K
derived: sum of 3 quarters · filed 2023-03-08
$857.60K
10-K · filed 2023-03-08
2021-09-30-$393.19K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$70.88K
derived: sum of 2 quarters · filed 2022-11-09
$204.90K
10-Q · filed 2022-11-09
$498.92K
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30$464.07K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$598.08K
10-Q · filed 2022-08-09
$892.11K
derived: sum of 3 quarters · filed 2022-08-09
-$1.54M
derived: sum of 4 quarters · filed 2022-08-09
2021-03-31$134.01K
10-Q · filed 2022-05-04
$428.04K
derived: sum of 2 quarters · filed 2022-05-04
-$2.01M
derived: sum of 3 quarters · filed 2022-05-04
-$1.87M
derived: sum of 4 quarters · filed 2022-05-04
2020-12-31$294.03K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
-$2.14M
derived: sum of 2 quarters · filed 2022-03-01
-$2.01M
derived: sum of 3 quarters · filed 2022-03-01
-$1.32M
10-K · filed 2022-03-01
2020-09-30-$2.44M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08
-$2.30M
derived: sum of 2 quarters · filed 2021-11-08
-$1.62M
10-Q · filed 2021-11-08
-$4.63M
derived: sum of 4 quarters · filed 2021-11-08
2020-06-30$135.50K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-02
$821.55K
10-Q · filed 2021-08-02
-$2.19M
derived: sum of 3 quarters · filed 2021-08-02
$196.77K
derived: sum of 4 quarters · filed 2021-08-02
2020-03-31$686.05K
10-Q · filed 2021-05-12
-$2.33M
derived: sum of 2 quarters · filed 2021-05-12
$61.27K
derived: sum of 3 quarters · filed 2021-05-12
-$22.51K
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31-$3.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08
-$624.78K
derived: sum of 2 quarters · filed 2021-03-08
-$708.56K
derived: sum of 3 quarters · filed 2021-03-08
$517.34K
10-K · filed 2021-03-08
2019-09-30$2.39M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02
$2.30M
derived: sum of 2 quarters · filed 2020-11-02
$3.53M
10-Q · filed 2020-11-02
$4.46M
derived: sum of 4 quarters · filed 2020-11-02
2019-06-30-$83.78K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03
$1.14M
10-Q · filed 2020-08-03
$2.07M
derived: sum of 3 quarters · filed 2020-08-03
$1.63M
derived: sum of 4 quarters · filed 2020-08-03
2019-03-31$1.23M
10-Q · filed 2020-05-04
$2.15M
derived: sum of 2 quarters · filed 2020-05-04
$1.72M
derived: sum of 3 quarters · filed 2020-05-04
$200.63K
derived: sum of 4 quarters · filed 2020-05-04
2018-12-31$924.92K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09
$489.82K
derived: sum of 2 quarters · filed 2020-03-09
-$1.03M
derived: sum of 3 quarters · filed 2020-03-09
$364.03K
10-K · filed 2020-03-09
2018-09-30-$435.09K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04
-$1.95M
derived: sum of 2 quarters · filed 2019-11-04
-$560.89K
10-Q · filed 2019-11-04
-$628.66K
derived: sum of 4 quarters · filed 2019-11-04
2018-06-30-$1.52M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05
-$125.79K
10-Q · filed 2019-08-05
-$193.57K
derived: sum of 3 quarters · filed 2019-08-05
-$97.83K
derived: sum of 4 quarters · filed 2019-08-05
2018-03-31$1.39M
10-Q · filed 2019-05-06
$1.32M
derived: sum of 2 quarters · filed 2019-05-06
$1.42M
derived: sum of 3 quarters · filed 2019-05-06
-$450.51K
derived: sum of 4 quarters · filed 2019-05-06
2017-12-31-$67.78K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12
$27.97K
derived: sum of 2 quarters · filed 2019-03-12
-$1.84M
derived: sum of 3 quarters · filed 2019-03-12
-$32.70K
10-K · filed 2019-03-12
2017-09-30$95.74K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05
-$1.77M
derived: sum of 2 quarters · filed 2018-11-05
$35.07K
10-Q · filed 2018-11-05
$670.18K
derived: sum of 4 quarters · filed 2018-11-05
2017-06-30-$1.87M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
-$60.67K
10-Q · filed 2018-08-02
$574.44K
derived: sum of 3 quarters · filed 2018-08-02
$667.71K
derived: sum of 4 quarters · filed 2018-08-02
2017-03-31$1.81M
10-Q · filed 2018-05-03
$2.44M
derived: sum of 2 quarters · filed 2018-05-03
$2.54M
derived: sum of 3 quarters · filed 2018-05-03
$2.05M
derived: sum of 4 quarters · filed 2018-05-03
2016-12-31$635.11K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12
$728.38K
derived: sum of 2 quarters · filed 2018-03-12
$244.38K
derived: sum of 3 quarters · filed 2018-03-12
$107.77K
10-K · filed 2018-03-12
2016-09-30$93.27K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06
-$390.73K
derived: sum of 2 quarters · filed 2017-11-06
-$527.34K
10-Q · filed 2017-11-06
$98.43K
derived: sum of 4 quarters · filed 2018-03-12
2016-06-30-$484.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03
-$620.61K
10-Q · filed 2017-08-03
$5.16K
derived: sum of 3 quarters · filed 2018-03-12
$175.67K
derived: sum of 4 quarters · filed 2018-03-12
2016-03-31-$136.61K
10-Q · filed 2017-05-04
$489.16K
derived: sum of 2 quarters · filed 2018-03-12
$659.67K
derived: sum of 3 quarters · filed 2018-03-12
$327.62K
derived: sum of 4 quarters · filed 2018-03-12
2015-12-31$625.77K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12
$796.28K
derived: sum of 2 quarters · filed 2018-03-12
$464.23K
derived: sum of 3 quarters · filed 2018-03-12
$718.76K
10-K · filed 2018-03-12
2015-09-30$170.51K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
-$161.54K
derived: sum of 2 quarters · filed 2016-11-03
$92.98K
10-Q · filed 2016-11-03
-$197.18K
derived: sum of 4 quarters · filed 2017-03-13
2015-06-30-$332.05K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
-$77.52K
10-Q · filed 2016-08-04
-$367.69K
derived: sum of 3 quarters · filed 2017-03-13
-$938.19K
derived: sum of 4 quarters · filed 2017-03-13
2015-03-31$254.53K
10-Q · filed 2016-05-03
-$35.64K
derived: sum of 2 quarters · filed 2017-03-13
-$606.14K
derived: sum of 3 quarters · filed 2017-03-13
-$563.92K
derived: sum of 4 quarters · filed 2017-03-13
2014-12-31-$290.17K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13
-$860.66K
derived: sum of 2 quarters · filed 2017-03-13
-$818.45K
derived: sum of 3 quarters · filed 2017-03-13
$368.70K
10-K · filed 2017-03-13
2014-09-30-$570.50K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
-$528.29K
derived: sum of 2 quarters · filed 2015-11-05
$658.86K
10-Q · filed 2015-11-05
2014-06-30$42.21K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05
$1.23M
10-Q · filed 2015-08-05
2014-03-31$1.19M
10-Q · filed 2015-05-07
2013-12-31$522.98K
10-K · filed 2015-03-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tonix Pharmaceuticals Holding Corp. (TNXP)United States$0.166B-1.34
ADC Therapeutics SA (ADCT)$0.163B-1.39
LIFECORE BIOMEDICAL, INC. DE (LFCR)United States$0.163B-8.50
Organogenesis Holdings Inc. (ORGO)United States$0.182B-3.70
Annexon, Inc. (ANNX)United States$0.147B-4.22
AN2 Therapeutics, Inc. (ANTX)United States$0.185B-4.84
PepGen Inc. (PEPG)United States$0.186B-1.73
Corbus Pharmaceuticals Holdings, Inc. (CRBP)United States$0.144B-1.72
ALX ONCOLOGY HOLDINGS INC (ALXO)United States$0.187B-3.52
Fortress Biotech, Inc. (FBIO)United States$0.188B0.91